Literature DB >> 3826664

Halothane hepatotoxicity in guinea pigs.

R C Lind, A J Gandolfi, B R Brown, P M Hall.   

Abstract

A recently reported animal model of halothane-associated hepatotoxicity in males of a colored strain of guinea pig was further characterized as to possible sex and strain specificity in outbred albino Amana, inbred albino Hartley, inbred colored strain 2, and inbred colored strain 13 guinea pigs. Exposure to 1% halothane for 4 hr in 21% O2 proved to be hepatotoxic in both sexes. Forty-eight hours after halothane exposure fatty vacuolization of hepatocytes was present in all animals. Histologically identifiable hepatic necrosis occurred in 60% of the guinea pigs exposed, along with concomitant increases in SGPT. Approximately one half of these responding animals had extensive centrilobular necrosis, which was still present 96 hr after halothane exposure. Females of the inbred strain 2 and males and females of strain 13 were the most susceptible to halothane-induced hepatic necrosis whereas the inbred Hartley strain was almost totally refractory to necrosis. Outbred Amana and male inbred strain 2 animals exhibited an intermediate hepatotoxic response. Comparison of the halothane-associated hepatic lesion with that induced by anoxic/ischemic mechanisms, (exposure to low (8%) oxygen during 1.7% enflurane anesthesia) showed obvious differences in the morphology of the hepatic necrosis and the apparent time course of lesion development. This guinea pig model of halothane-associated hepatotoxicity appears to be superior to previous animal models in that no pretreatment of the guinea pigs is required, both sexes are affected, and the resulting hepatic lesion is more persistent.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3826664

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


  3 in total

1.  The pathology of halothane hepatotoxicity in a guinea-pig model: a comparison with human halothane hepatitis.

Authors:  C A Lunam; P M Hall; M J Cousins
Journal:  Br J Exp Pathol       Date:  1989-10

2.  A mouse model of severe halothane hepatitis based on human risk factors.

Authors:  Christine M Dugan; Allen E MacDonald; Robert A Roth; Patricia E Ganey
Journal:  J Pharmacol Exp Ther       Date:  2010-02-02       Impact factor: 4.030

3.  Localization of halothane-induced antigen in situ by specific anti-halothane metabolite antibodies.

Authors:  A K Hubbard; T P Roth; S Schuman; A J Gandolfi
Journal:  Clin Exp Immunol       Date:  1989-06       Impact factor: 4.330

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.